Integrated genomic characterization of endometrial carcinoma

od Levine, Douglas A.
Izdano 2013

Study design and data analysis considerations for the discovery of prognostic molecular biomarkers: a case study of progression free survival in advanced serous ovarian cancer

od Qin, Li-Xuan, Levine, Douglas A.
izdano v BMC Med Genomics (2016)

Evaluating cell lines as tumour models by comparison of genomic profiles

od Domcke, Silvia, Sinha, Rileen, Levine, Douglas A., Sander, Chris, Schultz, Nikolaus
Izdano 2013

Time to Recurrence and Survival in Serous Ovarian Tumors Predicted from Integrated Genomic Profiles

od Mankoo, Parminder K., Shen, Ronglai, Schultz, Nikolaus, Levine, Douglas A., Sander, Chris
Izdano 2011

The genomic heterogeneity of FIGO grade 3 endometrioid carcinoma: impacts on diagnostic accuracy and reproducibility

od Hussein, Yaser R, Broaddus, Russell, Weigelt, Britta, Levine, Douglas A, Soslow, Robert A
izdano v Int J Gynecol Pathol (2016)

Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma

od Zhang, Shuang, Dolgalev, Igor, Zhang, Tao, Ran, Hao, Levine, Douglas A., Neel, Benjamin G.
izdano v Nat Commun (2019)

A pair of datasets for microRNA expression profiling to examine the use of careful study design for assigning arrays to samples

od Qin, Li-Xuan, Huang, Huei-Chung, Villafania, Liliana, Cavatore, Magali, Olvera, Narciso, Levine, Douglas A.
izdano v Sci Data (2018)

Pathological Scoring of PTEN Immunohistochemistry in Endometrial Carcinoma is Highly Reproducible

od Garg, Karuna, Broaddus, Russell R., Soslow, Robert A, Urbauer, Diana L., Levine, Douglas A, Djordjevic, Bojana
izdano v Int J Gynecol Pathol (2012)

Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study

od Vang, Russell, Levine, Douglas A., Soslow, Robert A., Zaloudek, Charles, Shih, Ie-Ming, Kurman, Robert J.
izdano v Int J Gynecol Pathol (2016)

Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade

od Jelinic, Petar, Ricca, Jacob, Van Oudenhove, Elke, Olvera, Narciso, Merghoub, Taha, Levine, Douglas A, Zamarin, Dmitriy
izdano v J Natl Cancer Inst (2018)

Comprehensive Mutation Profiling by Next-Generation Sequencing of Effusion Fluids From Patients With High-Grade Serous Ovarian Carcinoma

od Shah, Ronak H., Scott, Sasinya N., Brannon, A. Rose, Levine, Douglas A., Lin, Oscar, Berger, Michael F.
izdano v Cancer Cytopathol (2015)

The EMSY threonine 207 phospho-site is required for EMSY-driven suppression of DNA damage repair

od Jelinic, Petar, Eccles, Laura A., Tseng, Jill, Cybulska, Paulina, Wielgos, Monicka, Powell, Simon N., Levine, Douglas A.
izdano v Oncotarget (2017)

BACOM2.0 facilitates absolute normalization and quantification of somatic copy number alterations in heterogeneous tumor

od Fu, Yi, Yu, Guoqiang, Levine, Douglas A., Wang, Niya, Shih, Ie-Ming, Zhang, Zhen, Clarke, Robert, Wang, Yue
izdano v Sci Rep (2015)

Multi-Gene Expression Predictors of Single Drug Responses to Adjuvant Chemotherapy in Ovarian Carcinoma: Predicting Platinum Resistance

od Ferriss, J. Stuart, Kim, Youngchul, Duska, Linda, Birrer, Michael, Levine, Douglas A., Moskaluk, Christopher, Theodorescu, Dan, Lee, Jae K.
Izdano 2012

Successful eradication of established peritoneal ovarian tumors in SCID-Beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigen

od Chekmasova, Alena A., Rao, Thapi D., Nikhamin, Yan, Park, Kay J., Levine, Douglas A., Spriggs, David R., Brentjens, Renier J.
Izdano 2010

Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer

od Konstantinopoulos, Panagiotis A., Spentzos, Dimitrios, Karlan, Beth Y., Taniguchi, Toshiyasu, Fountzilas, Elena, Francoeur, Nancy, Levine, Douglas A., Cannistra, Stephen A.
Izdano 2010

A Phase II Trial of Erlotinib in Patients with Previously Treated Squamous Cell and Adenocarcinoma of the Esophagus

od Ilson, David H., Kelsen, David, Shah, Manish, Schwartz, Gary, Levine, Douglas A., Boyd, Jeff, Capanu, Marinela, Miron, Benjamin, Klimstra, David
Izdano 2010

UNDO: a Bioconductor R package for unsupervised deconvolution of mixed gene expressions in tumor samples

od Wang, Niya, Gong, Ting, Clarke, Robert, Chen, Lulu, Shih, Ie-Ming, Zhang, Zhen, Levine, Douglas A., Xuan, Jianhua, Wang, Yue
izdano v Bioinformatics (2015)

Identification of Tumor Suppressors and Oncogenes from Genomic and Epigenetic Features in Ovarian Cancer

od Wrzeszczynski, Kazimierz O., Varadan, Vinay, Byrnes, James, Lum, Elena, Kamalakaran, Sitharthan, Levine, Douglas A., Dimitrova, Nevenka, Zhang, Michael Q., Lucito, Robert
Izdano 2011

BRCA Germline Mutations in Jewish Patients With Pancreatic Adenocarcinoma

od Ferrone, Cristina R., Levine, Douglas A., Tang, Laura H., Allen, Peter J., Jarnagin, William, Brennan, Murray F., Offit, Kenneth, Robson, Mark E.
Izdano 2009